P. Kent Hawryluk
President & CEO at MBX Biosciences Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: MBX Biosciences Inc., 2 years.
MBX Biosciences Inc.
Director · President & CEO
Chief executive roles
MBX Biosciences Inc.
· President & CEO
Since September 2024
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 4, 2025 | MBX Biosciences Inc. | Open-market purchase | +50,000 | $10.69 | $534,500 |
| Sep 16, 2024 | MBX Biosciences Inc. | Derivative conversion | +283,846 | — | — |
| Sep 16, 2024 | MBX Biosciences Inc. | Derivative conversion | +115,914 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.